HQ Function

The headquarters serves as the central hub for research and development, clinical trial oversight, corporate strategy, and administrative operations.

Notable Features:

Located within a research park environment, likely providing access to state-of-the-art laboratory facilities, vivarium, and collaborative spaces conducive to cutting-edge biotech research. Proximity to Stony Brook University and its medical center offers potential for academic and clinical collaborations.

Work Culture:

A dynamic, science-driven environment focused on innovation, collaboration, and a strong sense of urgency to bring life-changing therapies to patients. The culture likely encourages intellectual curiosity and a patient-first mindset.

HQ Significance:

The Stony Brook headquarters is critical for advancing iCell's proprietary CAR-T platforms and managing its pipeline of clinical candidates targeting various cancers. It's the core of their scientific innovation and operational execution.

Values Reflected in HQ: The headquarters' focus on advanced research facilities reflects values of scientific excellence, innovation, and a commitment to developing next-generation cancer therapies.

Location:

iCell Gene Therapeutics operates with a strategic global footprint, anchored by its R&D and corporate headquarters in Stony Brook, New York, USA. This US base drives primary research, US clinical trial management, and global strategy. Complementing this, the company has a significant presence in Shanghai, China, which focuses on clinical development, research collaborations, and strategic initiatives within the Asian market. This dual-center approach allows iCell to leverage talent, resources, and patient populations across key international regions for its innovative cell therapy programs.

Street Address:

25 Health Sciences Drive, Suite 106

City:

Stony Brook

State/Province:

New York

Country:

USA